Genmab A/S GMAB 价格预测与展望

Q: 技术分析指标如何适用于 GMAB？

根据技术分析，Genmab A/S 的综合信号为 Buy。Genmab A/S 有 3 个买入信号，2 个中性信号和 2 个卖出信号。

Q: GMAB 的斐波那契回调水平是多少？

Genmab A/S 的斐波那契回调水平是 在 61.8% 和 78.6% 之间。

Q: Genmab A/S 的 RSI 是多少？

Genmab A/S 的 RSI 目前为 35.18，表明处于 中立 状态

Q: Genmab A/S 接下来 12 个月的价格是多少？

Genmab A/S GMAB 接下来 12 个月的价格预计为 $28.4。

Q: Genmab A/S 预计会涨到多高？

据华尔街分析师称，Genmab A/S 预计将达到 $182.9 的高预测值。

主页

股票

GMAB

预测

GMAB 股票价格预测

Genmab A/S

$31.33

-2.85%

$-0.92

收盘价：Jan 20, 16:00:00 GMT-5

$31.4

0.22%

$0.07

盘后：Jan 20, 20:00:00 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$32.25

开盘价

$31.38

当日区间

$31.05 - $31.68

52周范围

$17.23 - $35.43

交易量

2.7M

平均成交量

1.8M

每股收益（TTM）

2.29

股息收益率

市值

$19.3B

什么是 Genmab A/S？

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. The company specializes in the creation and development of antibody therapeutics for the treatment of cancer. The firm is the creator of the approved antibodies: DARZALEX (daratumumab) for the treatment of certain multiple myeloma indications, Kesimpta for the treatment of adults with relapsing forms of multiple sclerosis, TEPEZZA (teprotumumab) for the treatment of thyroid eye disease and FASPRO, for the treatment of adult patients with certain multiple myeloma indications. The first approved Genmab created therapy Arzerra, approved for the treatment of certain chronic lymphocytic leukemia indications, is available in Japan and is also available in other territories via compassionate use or oncology access programs. Genmab develops a broad clinical and pre-clinical product pipeline, and owns four antibody technologies, DuoBody bispecific platform, HexaBody platform, DuoHexaBody platform & HexElect platform.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for GMAB in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $28.4. The lowest target is $-146.6338 and the highest is $182.9. Empower your investment choices with our cutting-edge, data-driven analysis!

GMAB 股价预测摘要

GMAB的顶级分析师评级

基于 26 位分析师对 GMAB 的股票评级，更新于 Nov 01, 2025

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for GMAB. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: GMAB is a Buy candidate.

GMAB stock price ended at $31.33 on 星期二, after dropping 2.85%

On the latest trading day Jan 20, 2026, the stock price of GMAB fell by 2.85%, dropping from $31.38 to $31.33. During the session, the stock saw a volatility of 1.51%, with prices oscillating between a daily low of $31.04 and a high of $31.51. On the latest trading day, the trading volume for GMAB decreased by 5.8M shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 361.6K shares were traded, with a market value of approximately $19.2B.

GMAB 技术面信号

技术面信号摘要

购买信号 3

中性信号 2

卖出信号 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

GMAB目前显示3个买入信号和2个卖出信号。该股票自12:00 AM以来一直处于下降趋势状态，在此期间价格总变动为-11.35%。总体而言，技术指标显示中期前景为Buy。

GMAB 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 GMAB 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 GMAB？



GMAB 的斐波那契回调水平是多少？



Genmab A/S 的 RSI 是多少？



Genmab A/S 接下来 12 个月的价格是多少？



Genmab A/S 预计会涨到多高？



Genmab A/S（GMAB）价格

GMAB 股价走势图